COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,187 Articles (22,713 medRxiv, 8,474 bioRxiv)

Most recent first Previous |  Page 145: Articles 1441-1450  | Next

Virological characteristics of the SARS-CoV-2 XEC variant
Kaku, Y., Okumura, K., Kawakubo, S., Uriu, K., Chen, L., Kosugi, Y., Uwamino, Y., Begum, M. M., Leong, S., Ikeda, T., Sadamasu, K., Asakura, H., Nagashima, M., Yoshimura, K., The Genotype to Phenotype Japan (G2P-Japan) Consortium, , Ito, J., Sato, K.
10.1101/2024.10.16.618773 — Posted: 2024-10-17
Comparison of nasopharyngeal swab and oral fluid collected by ORACOL Saliva Collection System for molecular detection of SARS-CoV-2
Barbezange, C., Hutse, V., Roukaerts, I., Thomas, I., Tobback, E., Callens, S., De Scheerder, M.-A., Padalko, E.
10.1101/2024.10.15.24315521 — Posted: 2024-10-16
Evaluating Long-Term Autonomic Dysfunction and Functional Impacts of Long COVID: A Follow-Up Study
Eastin, E., Machnik, J., Larsen, N., Seliger, J., Geng, L. N., Bonilla, H., Yang, P., Stiles, L., Miglis, M. G.
10.1101/2024.10.11.24315277 — Posted: 2024-10-16
Mechanistic insights into the activity of SARS-CoV-2 RNA polymerase inhibitors using single-molecule FRET
Groves, D., Cunnison, R., McMahon, A., Fan, H., Sharps, J., Deng, A., Keown, J. R., Fodor, E., Robb, N. C.
10.1101/2024.10.15.618435 — Posted: 2024-10-16
A Reproducibility Focused Meta-Analysis Method for Single-Cell Transcriptomic Case-Control Studies Uncovers Robust Differentially Expressed Genes
Nakatsuka, N. J., Adler, D., Jiang, L., Hartman, A., Cheng, E., Klann, E., Satija, R.
10.1101/2024.10.15.618577 — Posted: 2024-10-16
SARS-CoV-2 outbreak in lions, tigers and hyenas at Denver Zoo
Gallichotte, E. N., Bashor, L., Erbeck, K., Croft, L., Stache, K., Long, J., VandeWoude, S., Johnson, J., Pabilonia, K., Ebel, G.
10.1101/2024.10.14.617443 — Posted: 2024-10-16
Longitudinal profiling of B cells primed by mRNA vaccine and recalled by Omicron variants uncovers antibodies broadly neutralizing sarbecoviruses
Chen, X., Li, L., Du, R., Wang, Z., Li, Y., Sun, Y., Qin, R., Feng, H., Hu, L., Chen, X., Lu, M., Huang, X., Jiang, L., Zuo, T.
10.1101/2024.10.13.618110 — Posted: 2024-10-16
Comparative evaluation of methodologies for estimating the effectiveness of non-pharmaceutical interventions in the context of COVID-19: a simulation study
Ganser, I., Paireau, J., Buckeridge, D. L., Cauchemez, S., Thiebaut, R., Prague, M.
10.1101/2024.10.14.24314896 — Posted: 2024-10-15
A modular approach to forecasting COVID-19 hospital bed occupancy
Tobin, R. J., Walker, C. R., Moss, R., McCaw, J., Price, D. J., Shearer, F. M.
10.1101/2024.10.13.24314968 — Posted: 2024-10-15
Analysis of the functioning of temporary dialysis catheters in patients with COVID-19
Ponte, B. J., Dib, V. G., Portela, F. S. O., Magnani, A. S., Silva, M. J., Pinheiro, L. L., Wolosker, N.
10.1101/2024.10.14.24314426 — Posted: 2024-10-15

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).